Protalix BioTherapeutics to Participate in Upcoming September 2026 Investor Conferences
Protalix BioTherapeutics announced that CFO Gilad Mamlok will participate in two investor conferences in New York City in September 2026. The company presents at the H.C. Wainwright 28th Annual Global Investment Conference on Monday, September 14, 2026 at 2:00 p.m. EDT, and joins a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16, 2026 at 1:05 p.m.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.